Elza Maria Hartmann Uberti

Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.

Antônio Braga, Elza Maria Hartmann Uberti, Maria do Carmo Fajardo et al. · PubMed · 2014 · 61 citations

Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women

Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Adriana Gerhardt Vieira da Cunha et al. · Revista Brasileira Ginecologia e Obstetrícia · 2015 · 43 citations · Full text

Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: A simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment

Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Adriana Gerhardt Vieira da Cunha et al. · Gynecologic Oncology · 2009 · 28 citations

Actinomycin D, High-risk Hydatidiform Mole, Gynecology +4

Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries.

Antônio Braga, Marcelo Burlá, Fernanda Freitas et al. · PubMed · 2016 · 20 citations

Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole

Elza Maria Hartmann Uberti, M.C.F. Diestel, Fernando E. Guimarães et al. · Gynecologic Oncology · 2006 · 19 citations

Single-dose Actinomycin D, High-risk Hydatidiform Mole, Pediatrics +3